TriMas Announces Fourth Quarter and Full Year 2022 Earnings Conference Call DateBusiness Wire • 01/31/23
Newron announces striking six-month interim results from its exploratory clinical trial evaluating evenamide as add-on therapy for patients with treatment-resistant schizophreniaBusiness Wire • 01/03/23
TriMas Packaging Facility Achieves FSSC 22000, a Leading Food Safety Production CertificationBusiness Wire • 12/07/22
TriMas' 2022 Kaizen Challenge Winners Reflect Ongoing Commitment to Continuous ImprovementBusiness Wire • 12/02/22
TriMas to Present at the Bank of America Securities 2022 Leveraged Finance ConferenceBusiness Wire • 11/28/22
TriMas Corporation (TRS) CEO Thomas Amato on Q2 2022 Results - Earnings Call TranscriptSeeking Alpha • 07/30/22
TriMas Corporation (TRS) CEO Tom Amato On Q1 2022 Results - Earnings Call TranscriptSeeking Alpha • 04/30/22